ClinicalTrials.gov record
Completed Phase 2 Interventional Results available

A Study of TAK-079 in People With Generalized Myasthenia Gravis

ClinicalTrials.gov ID: NCT04159805

Public ClinicalTrials.gov record NCT04159805. Field values are reproduced from the official study page; the official ClinicalTrials.gov record remains the source of truth for eligibility, enrollment, and contact information.

ClinicalTrials.gov public records Last synced May 12, 2026, 3:12 PM EDT

Data is sourced from official ClinicalTrials.gov public API records. Always review the official ClinicalTrials.gov record for the latest information.

Official title

A Phase 2, Randomized, Placebo-Controlled Study to Evaluate Safety, Tolerability, and Efficacy of TAK-079 in Patients With Generalized Myasthenia Gravis

Study identification

NCT ID
NCT04159805
Recruitment status
Completed
Study type
Interventional
Phase
Phase 2
Lead sponsor
Takeda
Industry
Enrollment
36 participants

Conditions and interventions

Interventions

  • TAK-079 Drug
  • TAK-079 Placebo Drug

Drug

Eligibility (public fields only)

Age range
18 Years and older
Sex
All
Healthy volunteers
Healthy volunteers not accepted

This page does not interpret eligibility. Detailed inclusion and exclusion criteria are on the official ClinicalTrials.gov record.

Study timeline

Start date
Jan 13, 2020
Primary completion
Jul 11, 2022
Completion
Jul 11, 2022
Last update posted
Jun 1, 2023

2020 – 2022

United States locations

U.S. sites
27
U.S. states
15
U.S. cities
24
Facility City State ZIP Site status
The University of Arizona Medical Center Tucson Arizona 85713
Stanford Neuroscience Health Center Palo Alto California 94304
University of California Davis Medical Center Sacramento California 95816
University of California Davis Medical Center Sacramento California 95817
University of Colorado Hospital Aurora Colorado 80045
George Washington University Washington D.C. District of Columbia 20037
SFM Clinical Research, LLC Boca Raton Florida 33487
Neurology Associates PA Maitland Florida 32751
Medsol Clinical Research Center Inc Port Charlotte Florida 33952
Augusta University Augusta Georgia 30912
Consultants In Neurology Northbrook Illinois 60062
University of Kansas Medical Center Kansas City Kansas 66160
Wayne State University Detroit Michigan 48201
Henry Ford Health System Detroit Michigan 48202
Michigan State University East Lansing Michigan 48824
Neurology and Sleep Disorders Clinic Columbia Missouri 65212
Hospital For Special Surgery New York New York 10021
University of North Carolina at Chapel Hill Chapel Hill North Carolina 27514
Carolinas HealthCare System Neurosciences Institute-Neurology Charlotte North Carolina 28207
Duke University Medical Center Durham North Carolina 27710
University of Cincinnati Cincinnati Ohio 45267
Ohio State University Medical Center Columbus Ohio 43210
Austin Neuromuscular Center Austin Texas 78756
The University of Texas South Western Medical Center Dallas Texas 75390
Central Texas Neurology Consultants PA Round Rock Texas 78681
Center for Neurological Disorders Milwaukee Wisconsin 53215
The Medical College of Wisconsin, Inc. Milwaukee Wisconsin 53226

Site contact phone numbers, emails, and investigator names are intentionally not displayed here. Open the official ClinicalTrials.gov record for site contact information.

Non-U.S. locations

This page focuses on the U.S. directory. The official record also lists 23 non-U.S. sites.

About this trial record page

What this page shows
Public field values for ClinicalTrials.gov record NCT04159805, including study identification, conditions, interventions, eligibility (age, sex, healthy volunteer), timeline, and U.S. site list.
What this page does not do
No medical advice, eligibility judgments, treatment recommendations, study quality scoring, or AI-generated medical summaries. No site contact phone numbers, emails, or investigator names.
Where the data comes from
Sourced from the official ClinicalTrials.gov public API. The official record is the source of truth.
Last refresh
Last update posted Jun 1, 2023 · Synced May 12, 2026

Related: full search, browse by condition, browse by drug or therapy, browse by sponsor, browse by U.S. city.

Open the official record

The complete protocol, eligibility criteria, and contact information for NCT04159805 live on ClinicalTrials.gov.

View official ClinicalTrials.gov record →